ATHA

Athira Pharma (ATHA)

Athira Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ATHA

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/25	08:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/05/25	07:58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/05/25	07:56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/05/18	06:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc
2024/05/18	06:00	GlobeNewswire Inc.	Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action	NASDAQ:ATHA	Athira Pharma Inc
2024/05/16	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc
2024/05/16	05:05	GlobeNewswire Inc.	Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates	NASDAQ:ATHA	Athira Pharma Inc
2024/05/02	20:00	GlobeNewswire Inc.	Athira Pharma to Participate in Upcoming May Conferences	NASDAQ:ATHA	Athira Pharma Inc
2024/04/15	20:00	GlobeNewswire Inc.	Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer	NASDAQ:ATHA	Athira Pharma Inc
2024/04/11	20:00	GlobeNewswire Inc.	Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease	NASDAQ:ATHA	Athira Pharma Inc
2024/04/03	20:00	GlobeNewswire Inc.	Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting	NASDAQ:ATHA	Athira Pharma Inc
2024/03/08	21:00	GlobeNewswire Inc.	Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference	NASDAQ:ATHA	Athira Pharma Inc
2024/02/23	06:34	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:ATHA	Athira Pharma Inc
2024/02/23	06:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc
2024/02/23	06:05	GlobeNewswire Inc.	Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	07:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:46	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:40	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:37	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ATHA	Athira Pharma Inc
2024/02/17	06:32	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ATHA	Athira Pharma Inc
2024/02/09	06:02	GlobeNewswire Inc.	Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/09	06:35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ATHA	Athira Pharma Inc
2024/01/08	21:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ATHA	Athira Pharma Inc
2024/01/08	21:00	GlobeNewswire Inc.	Athira Pharma Provides 2024 Clinical Pipeline Outlook and Business Update	NASDAQ:ATHA	Athira Pharma Inc
2024/01/03	21:00	GlobeNewswire Inc.	Athira Pharma Completes Enrollment of Phase 2/3 LIFT-AD Clinical Trial of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease	NASDAQ:ATHA	Athira Pharma Inc